Dickinson, Catherine M.
LeBlanc, Brian W.
Edhi, Muhammad M.
Heffernan, Daithi S.
Faridi, Mohd. Hafeez
Gupta, Vineet
Cioffi, William G.
O’Brien, Xian
Reichner, Jonathan S.
Funding for this research was provided by:
National Institutes of Health (T32 GM065085, RO1 HL125265, RO1 DK084195, RO1 DK107984, KO8 GM110495)
Article History
Received: 6 September 2017
Accepted: 6 March 2018
First Online: 15 March 2018
Ethics approval and consent to participate
: This study was approved by the Rhode Island Hospital Institutional Review Board. All patient subjects or their designated spokesperson provided written consent for the blood draw.
: Not applicable
: Vineet Gupta is an inventor of pending patents related to this study and a co-founder and a member of the scientific advisory board of ADHAERE PHARMACEUTICALS, INC., a company developing novel therapeutics for inflammation, cancer, and autoimmune diseases. Therefore, Vineet Gupta has the potential for financial benefit from their future commercialization. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.